Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 4-Methylmorpholine | HCID 7972 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | Isobutyl chloroformate | HCID 62365 | — |
| Reactant | tert-Butyl cyanoacetate | HCID 70693 | — |
| Reactant | Tarenflurbil | HCID 92337 | — |
| Reactant | Hydroxyamine hydrochloride | HCID 443297 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Solvent | Ethanol | HCID 702 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 9925762 | HCID 9925762 | — |
Reaction Steps
Under a nitrogen atmosphere, tert-butyl cyanoacetate (0.57 ml) was added dropwise to a mixture of tetrahydrofuran (5 ml) and sodium hydride (160 mg, 60% oily) with stirring under ice-cooling. The resulting mixture was stirred for 10 minutes under ice-cooling, then stirred at room temperature for 20 minutes, and again stirred at 0° C. Separately, isobutyl chloroformate (0.26 ml) was added dropwise to a tetrahydrofuran solution (20 ml) of (R)-2-(2-fluoro-biphenyl-4-yl)-propionic acid (449 mg, 93% e.e.) and N-methylmorpholine (0.22 ml) at -15° C. with stirring. After 5 minutes, this solution was added dropwise to the previous mixture. After 20 minutes, this was poured into a saturated aqueous sodium bicarbonate solution and the resulting mixture was subjected to extraction with ethyl acetate. The organic layer was dried over sodium sulfate and then concentrated under reduced pressure. To the viscous residue thus obtained were added hydroxylamine hydrochloride (278 mg) and ethanol (10 ml), and the resulting mixture was stirred for 4 hours with heating under reflux. After cooling to room temperature, ethanol was removed by distillation, and a saturated aqueous sodium bicarbonate solution was added to the residue and the resulting mixture was subjected to extraction with ethyl acetate. The organic layer was dried over sodium sulfate and then concentrated under reduced pressure. The residue was purified by a silica gel column chromatography (hexane/ethyl acetate=3/2), to obtain the desired compound (226 mg, 93% e.e.).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06100260 |
|---|
| Source dataset | uspto-grants-2000_08 |
|---|
| ORD ID | ord-1036c1c2c39c401d80da623499e68dcd |
|---|
| Source note | uspto-grants-2000_08 |
|---|